CancerIQ
Helps clinicians identify, track, and manage patients with high genetic risk of cancer.
What they do
CancerIQ provides a software platform integrated into electronic health records to help healthcare systems identify patients at high risk for hereditary cancers. Clinicians use the tool to streamline genetic evaluation, risk-stratification, and compliance with personalized cancer prevention plans.
The record
- Vertical
- Oncology
- Sub-segment
- Cancer risk assessment
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- Chicago, United States
- Region
- North America
- Founded
- 2013
- Total funding
- $22M raised
Notable investors: Merck Global Health Innovation Fund, Amgen Ventures, McKesson Ventures, OSF Ventures.